What is the next best step in managing a 58-year-old man with LUTS, hematuria, and a 40g prostate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of LUTS with Hematuria in a 58-Year-Old Man

Cystoscopy is the next best step for this 58-year-old man with LUTS and microscopic hematuria. 1

Clinical Assessment

This patient presents with:

  • 58-year-old man with bothersome lower urinary tract symptoms (LUTS)
  • International Prostate Symptom Score (IPSS) of 18 (moderate-severe symptoms)
  • Sexually active and wants to preserve ejaculation
  • 40g smooth prostate on examination
  • Post-void residual (PVR) of 20 mL (normal)
  • PSA of 1.4 (normal)
  • Microscopic hematuria (4 RBCs per high-power field)

Rationale for Cystoscopy

The presence of microscopic hematuria in this patient is the critical finding that necessitates cystoscopic evaluation before proceeding with any LUTS treatment. According to guidelines:

  • Hematuria (microscopic or macroscopic) is a specific indication for endoscopic evaluation of the lower urinary tract 1
  • Upper urinary tract imaging and endoscopy are indicated in patients presenting with hematuria 1
  • When LUTS is associated with hematuria, the patient should be referred to a specialist (urologist) for appropriate evaluation before advising treatment 1

Management Algorithm

  1. First priority: Evaluate hematuria

    • Cystoscopy is indicated due to microscopic hematuria
    • This is necessary to rule out bladder cancer or other urologic pathology
  2. After excluding pathology:

    • If cystoscopy is negative, proceed with LUTS management
    • For a 40g prostate with moderate-severe symptoms (IPSS 18), medical therapy would be appropriate
  3. Medical therapy options after ruling out pathology:

    • Alpha-blocker (tamsulosin) would be appropriate for this prostate size
    • Finasteride would be considered for larger prostates (typically >40g) 2
  4. Minimally invasive procedures:

    • Prostatic urethral lift (PUL) or water vapor thermal therapy could be considered after ruling out pathology
    • These options preserve ejaculatory function, which is important to this patient

Why Not Other Options First?

  • Tamsulosin (Option A): While appropriate for LUTS with this prostate size, the presence of hematuria requires evaluation first
  • Finasteride (Option B): More appropriate for larger prostates (>40g); additionally, can cause sexual side effects including ejaculatory dysfunction 2
  • Prostatic Urethral Lift/UroLift (Option D): Preserves ejaculation but requires ruling out pathology first
  • Water Vapor Thermal Therapy (Option E): Preserves ejaculation but requires ruling out pathology first

Important Considerations

  • Microscopic hematuria (>3 RBCs per high-power field) requires evaluation regardless of LUTS severity
  • Delaying evaluation of hematuria could miss significant urologic pathology
  • The patient's desire to preserve ejaculatory function is important but secondary to ruling out serious pathology
  • After excluding pathology, treatment can be tailored to address both LUTS and sexual function preservation

The guidelines are clear that when LUTS is accompanied by hematuria, endoscopic evaluation is indicated before proceeding with treatment for LUTS 1. This approach prioritizes the detection of potentially serious conditions while still allowing for appropriate management of the patient's bothersome urinary symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.